Kenya BioVax Institute Limited

07/02/2026

held a strategic engagement meeting at the Embassy of Indonesia with H.E. Witjaksono Adji, discussing strengthened Kenya–Indonesia collaboration in health, research & development, and vaccine manufacturing.

The engagement explored opportunities for technical cooperation, knowledge exchange, and partnership in vaccine and biotherapeutics manufacturing, drawing on Indonesia’s experience and Kenya’s growing local manufacturing ambition. Discussions emphasized the importance of South–South partnerships in building resilient health systems, strengthening local manufacturing capacity, and advancing health security and pandemic preparedness across the Global South.

🇰🇪🤝🇮🇩

04/02/2026

The CEO of , Dr. Wesley Ronoh, paid a courtesy call on the Chairperson of the Departmental Committee on Health at the National Assembly, Hon. (Dr.) James Nyikal, during which they discussed strengthening policy and legislative support for local vaccine manufacturing, health security, and pandemic preparedness. The engagement also reviewed progress on the enabling works underway at Kenya BioVax toward achieving the country’s first locally manufactured vaccine vial, while underscoring Parliament’s critical role in anchoring sustainable financing, regulatory coherence, and public trust in locally produced vaccines as a cornerstone of Kenya’s healthcare system and national resilience.

Parliament of Kenya

04/02/2026

World Cancer Day 2026

On World Cancer Day, Kenya BioVax stands with patients, families, and communities affected by cancer. We remain committed to science, prevention, and partnerships that strengthen health systems and protect lives.

03/02/2026

Dr. Ken Simiyu paid a courtesy call to the Kenya BioVax Institute, where he held discussions with the CEO, Wesley Ronoh. With over 23 years of progressive global leadership in designing, grant-making, and managing the implementation of Science, Technology, and Innovation (STI) programmes, Dr. Simiyu engaged the Institute on opportunities to leverage the Kenya–USA Diaspora as a strategic asset for innovation, partnerships, and investment. The meeting highlighted the potential of diaspora expertise and networks in supporting Kenya’s ambitions in health innovation and biomanufacturing.

30/01/2026

Kenya BioVax Institute Limited paid a courtesy call to Tasa Pharma as part of ongoing engagements to strengthen collaboration within Kenya’s pharmaceutical manufacturing ecosystem. The visit provided an opportunity for knowledge exchange on quality systems, local manufacturing capabilities, and opportunities for partnership that support national and regional health security goals. The engagement reflects a shared commitment to advancing local production, skills transfer, and sustainable growth in the pharmaceutical and biotherapeutics sector.

28/01/2026

Day 2 of the Eastern Africa Regional Global Health Security Summit (EARGHSS 2026) spotlighted the theme of Enabling Local Manufacturing of Health Commodities, bringing together leaders shaping Africa’s health security agenda. Kenya BioVax Institute Limited participated in engagements led by CEO Dr. Wesley Ronoh, contributing to conversations on strengthening Africa’s capacity to locally manufacture vaccines, biotherapeutics, and essential health products as a cornerstone of pandemic preparedness and response.

The session convened a diverse group of stakeholders, including governments and regulators (The Ministry of Health and Pharmacy and Poisons Board ), Africa CDC, IGAD Secretariat and World Health Organization (WHO), regional manufacturers, development partners such as World Bank, academia, civil society, as well as digital health innovators and media. Discussions emphasized policy coherence, sustainable financing, technology transfer, regulatory maturity, and demand generation—collectively reinforcing the urgency of coordinated action to secure resilient, locally driven health supply chains for Africa’s future.

United States International University - Africa International Vaccine Institute Kenya Medical Research Institute Amref Health Africa in Kenya #

27/01/2026

Kenya BioVax Institute is proud to unveil the inaugural issue of Vaxcess (Issue No. 01 | January 2026), a thought-leadership and knowledge-sharing magazine dedicated to Africa’s journey in local vaccine and biotherapeutics manufacturing. Vaxcess spotlights the science, people, partnerships, and policy shaping health security on the continent—telling authentic stories from the lab bench to population impact. Through expert insights, field experiences, and strategic conversations, the magazine reflects our commitment to protecting health and promoting life by advancing sustainable, locally driven manufacturing ecosystems. Stay tuned as we share Africa’s manufacturing story—by Africans, for the world. 🌍💉

Link: https://biovax.go.ke/newsletters/

27/01/2026

🔬🤝 Kenya BioVax Institute production scientists, led by Dr. Cecilia Wanjala, General Manager – Commercial Services, paid a benchmarking visit to Cosmos Limited to exchange practical insights on end-to-end pharmaceutical production and quality systems. he engagement included guided facility tours and technical conversations with Cosmos teams, focusing on regulatory readiness, process optimization, and operational learning. The visit reflects a shared commitment to building strong local manufacturing capabilities, fostering peer learning, and advancing Kenya’s health security agenda through trusted industry partnerships. 🌍💊

26/01/2026

Ethio-Biopharma paid a courtesy call to Kenya BioVax Institute, reaffirming a shared commitment to strengthening regional collaboration in biopharmaceutical innovation and manufacturing. The engagement was received by Prof. Richard Oduor, General Manager, Research & Technology Transfer, representing the CEO, while Dr. Markos Abebe of Ethio-Biopharma led the visiting delegation. The meeting was attended by representatives from the World Bank , Kenya Development Corporation (KDC), IGAD Secretariat , and The Ministry of Health , among other stakeholders. Discussions focused on advancing strategic partnerships, strengthening knowledge and technology transfer, and accelerating Africa’s shared agenda for local manufacturing of vaccines and biotherapeutics to enhance continental health security and long-term self-reliance.

17/01/2026

16/01/2026

CALL FOR EXPRESSIONS OF INTEREST (EOI)

CONSULTING SERVICES FOR BIOMANUFACTURING ENVIRONMENTAL AND SOCIAL IMPACT ASSESSMENT (ESIA) OF THE KENYA BIOVAX FILL AND FINISH FACILITY IN EMBAKASI, NAIROBI, KENYA

Submission: HEPRR_Procurement@biovax.go.ke

15/01/2026

Dr. Mazyanga Lucy Mazaba, Regional Director – Eastern Africa at Africa Centres for Disease Control and Prevention, together with Emmanuel Kombe Nzai, Chairperson of Kenya Vision 2030, paid a courtesy call on the CEO of Kenya BioVax Institute, Dr. Wesley Ronoh. During the meeting, they reviewed progress and strategic preparations for the 2nd Eastern Africa Regional Global Health Security Summit (EARGHSS 2026), highlighting its role as a regional platform that brings together governments, public health institutions, manufacturers, and partners to assess preparedness, enhance coordination, share best practices, and strengthen collective responses to current and emerging public health threats across Eastern Africa, while aligning with Africa’s broader health security and local manufacturing priorities.